Analyst Coverage

Intercept Pharmaceuticals Raises Much Needed Cash As Shorts Accelerate Their Bets

After the market closed for trading on January 29, 2015, Intercept Pharmaceuticals (ICPT) released exciting news: ICPT’s “…investigational product obeticholic acid (OCA) has received “breakthrough therapy designation” from the U.S. Food and Drug Administration (FDA) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis. This indication constitutes a population of patients with … Read more

Rio Tinto Quickly Gives Up Gains from Morgan Stanley Upgrade

Two weeks ago, I noted Rio Tinto (RIO) as a prime short as a late responder to the on-going collapse in iron ore prices. On Monday (September 22), it broke down. Typically, I close out fortuitous short positions on such swift moves, but I am projecting RIO to go a lot lower over the next … Read more

Twitter’s Run-Up Reaching A Likely Crescendo

(This is an excerpt from an article I originally published on Seeking Alpha on December 27, 2013. Click here to read the entire piece.) Twitter (TWTR) is up 22% so far in this holiday shortened week and up 41% since December 10th when the stock broke out to its first post-IPO high. TWTR has been … Read more

First Solar Cashes Some Chips At A Good Time

(This is an excerpt from an article I originally published on Seeking Alpha on June 13, 2013. Click here to read the entire piece.) First Solar (FSLR) has run an “intriguing” script since making an all-time low last August… {snip} The offering of shares is of course well-timed given the run-up. With its currency this … Read more